31.
Nikas G, Drakakis P, Loutradis D, Mara-Skoufari C, Koumantakis E, Michalas S, et al. Uterine pinopodes as markers of the ‘nidation window’ in cycling women receiving exogenous oestradiol and progesterone. Human Reprod. 1995;10(5):1208–13.
33.
34.
35.
36.
37.
38.
39.
40.
Bergeron C. Morphological changes and protein secretion induced by progesterone in the endometrium during the luteal phase in preparation for nidation. Human Reprod. 2000;15 Suppl 1:119–28.CrossRef
41.
Su MT, Lee IW, Chen YC, Kuo PL. Association of progesterone receptor polymorphism with idiopathic recurrent pregnancy loss in Taiwanese Han population. J Assist Reprod Genet. 2011;28(3):239–43.PubMedCentralCrossRefPubMed
42.
43.
44.
45.
46.
47.
Arrowsmith S, Kendrick A, Wray S. Drugs acting on the pregnant uterus. Obstet Gynaecol Reprod Med. 2010;20(8):241–7.PubMedCentralCrossRefPubMed
48.
49.
Couzinet B, Le Strat N, Ulmann A, Baulieu EE, Schaison G. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone). N Engl J Med. 1986;315(25):1565–70.CrossRefPubMed